Is a complete INSP research report available?

No complete published report is available for Inspire Medical Systems, Inc. (INSP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Inspire Medical Systems, Inc. (INSP)

NYSE: INSP · USD

$71.1

-0.22 (-0.3%)· Recorded snapshot

Market cap	2.1B
Revenue (ttm)	898.7M
Net income (ttm)	135M
EPS (ttm)	$4.61
Shares out	28.9M
P/E (trailing)	15.4x
P/E (forward)	52.6x
Volume	238,650
Beta	0.73

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001609550
Company name	Inspire Medical Systems, Inc.
Country	United States
Country code	US
CUSIP number	457730109
Earnings date	2026-11-02
Earnings time	amc
Employees	1,333
Employees change	87
Employees growth	6.98%
Enterprise value	$1.8B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2007
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2018-05-03
Is primary listing	Yes
Is SPAC	No
ISIN number	US4577301090
Last 10-K release date	2026-02-13
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.1B
Market cap category	Mid-Cap
Next earnings date	2026-11-02
Options	Yes
Price	$71.08
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	INSP
U.S. state	Minnesota
Website	https://www.inspiresleep.com

Metric

Value

Amount currency

USD

CIK code

0001609550

Company name

Inspire Medical Systems, Inc.

Country

United States

Country code

CUSIP number

457730109

Earnings date

2026-11-02

Earnings time

amc

Employees

1,333

Employees change

Employees growth

6.98%

Enterprise value

$1.8B

Exchange

NYSE

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2007

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2018-05-03

Is primary listing

Yes

Is SPAC

ISIN number

US4577301090

Last 10-K release date

2026-02-13

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.1B

Market cap category

Mid-Cap

Next earnings date

2026-11-02

Options

Yes

Price

$71.08

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

INSP

U.S. state

Minnesota

Website

https://www.inspiresleep.com

Metric	Value
Adjusted P/E ratio	31.31x
Average P/E ratio (3Y)	131.96x
Earnings yield	6.48%
EV/Earnings	13.13x
EV/EBIT	32.76x
EV/EBITDA	24.86x
EV/FCF	15.14x
EV/Sales	1.97x
FCF / EV yield	6.6%
FCF yield	5.67%
Forward EV/Sales	2.05x
Forward P/E	52.64x
Forward P/S	2.39x
Graham number	54.4112
Graham upside	-23.82%
Industry forward P/E	19.74x
Industry P/E	39.16x
P/(OCF - SBC) ratio	54.8x
P/B ratio	2.5x
P/E ratio	15.43x
P/FCF ratio	17.63x
P/OCF ratio	13.15x
P/S ratio	2.3x
Price / tangible book value	2.5x
Price/EBITDA ratio	28.95x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Adjusted P/E ratio

31.31x

Average P/E ratio (3Y)

131.96x

Earnings yield

6.48%

EV/Earnings

13.13x

EV/EBIT

32.76x

EV/EBITDA

24.86x

EV/FCF

15.14x

EV/Sales

1.97x

FCF / EV yield

6.6%

FCF yield

5.67%

Forward EV/Sales

2.05x

Forward P/E

52.64x

Forward P/S

2.39x

Graham number

54.4112

Graham upside

-23.82%

Industry forward P/E

19.74x

Industry P/E

39.16x

P/(OCF - SBC) ratio

54.8x

P/B ratio

2.5x

P/E ratio

15.43x

P/FCF ratio

17.63x

P/OCF ratio

13.15x

P/S ratio

2.3x

Price / tangible book value

2.5x

Price/EBITDA ratio

28.95x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	6.02%
EBITDA margin	7.94%
FCF margin	13.03%
Gross margin	86.13%
Operating margin	6.02%
Pretax margin	7.72%
Profit margin	15.03%
Profit per employee	$101,307
Profitable quarters	1
Profitable years	2
Revenue per employee	$674,225
ROA	3.91%
ROA (5Y)	-2.57%
ROCE	6.33%
ROE	17.96%
ROE (5Y)	-1.28%
ROIC	10.1%
ROIC (5Y)	-42.63%
SBC / revenue	13.28%
Tax / revenue	-7.31%

Metric

Value

EBIT margin

6.02%

EBITDA margin

7.94%

FCF margin

13.03%

Gross margin

86.13%

Operating margin

6.02%

Pretax margin

7.72%

Profit margin

15.03%

Profit per employee

$101,307

Profitable quarters

Profitable years

Revenue per employee

$674,225

ROA

3.91%

ROA (5Y)

-2.57%

ROCE

6.33%

ROE

17.96%

ROE (5Y)

-1.28%

ROIC

10.1%

ROIC (5Y)

-42.63%

SBC / revenue

13.28%

Tax / revenue

-7.31%

Metric	Value
EPS growth	164.44%
EPS growth quarters	1
EPS growth years	3
FCF growth	37.74%
FCF growth (QoQ)	350.46%
FCF growth 3Y	83.5%
Gross profit growth	6.4%
Gross profit growth (Q)	-6.01%
Gross profit growth 3Y	20.72%
Gross profit growth 5Y	38.98%
Net income growth	154.22%
Net income growth quarters	1
Net income growth years	3
OCF growth	33.74%
OCF growth (Q)	765.43%
OCF growth (QoQ)	80.78%
OCF growth 3Y	66.52%
Operating income growth	30.73%
Revenue growth	4.35%
Revenue growth (Q)	-7.6%
Revenue growth (QoQ)	-1.96%
Revenue growth 3Y	19.54%
Revenue growth 5Y	38.69%
Revenue growth years	10

Metric

Value

EPS growth

164.44%

EPS growth quarters

EPS growth years

FCF growth

37.74%

FCF growth (QoQ)

350.46%

FCF growth 3Y

83.5%

Gross profit growth

6.4%

Gross profit growth (Q)

-6.01%

Gross profit growth 3Y

20.72%

Gross profit growth 5Y

38.98%

Net income growth

154.22%

Net income growth quarters

Net income growth years

OCF growth

33.74%

OCF growth (Q)

765.43%

OCF growth (QoQ)

80.78%

OCF growth 3Y

66.52%

Operating income growth

30.73%

Revenue growth

4.35%

Revenue growth (Q)

-7.6%

Revenue growth (QoQ)

-1.96%

Revenue growth 3Y

19.54%

Revenue growth 5Y

38.69%

Revenue growth years

Metric	Value
Capital expenditures	$-40M
Depreciation and amortization	$17.2M
EBIT	$54.1M
EBITDA	$71.3M
EPS	$4.61
FCF per share	$4.05
Financing cash flow	$-105M
Free cash flow	$117.1M
Free cash flow minus SBC	$-2.3M
Gross profit	$774.1M
Income taxes	$-65.7M
Investing cash flow	$-31.3M
Net cash flow	$20.8M
Net income	$135M
Operating cash flow minus SBC	$37.7M
Operating income	$54.1M
Revenue	$898.7M
Stock-based compensation	$119.4M

Metric

Value

Capital expenditures

$-40M

Depreciation and amortization

$17.2M

EBIT

$54.1M

EBITDA

$71.3M

EPS

$4.61

FCF per share

$4.05

Financing cash flow

$-105M

Free cash flow

$117.1M

Free cash flow minus SBC

$-2.3M

Gross profit

$774.1M

Income taxes

$-65.7M

Investing cash flow

$-31.3M

Net cash flow

$20.8M

Net income

$135M

Operating cash flow minus SBC

$37.7M

Operating income

$54.1M

Revenue

$898.7M

Stock-based compensation

$119.4M

Metric	Value
Altman Z-Score	15.39
Book value per share	$28.56
Debt / EBITDA	0.37
Debt / equity	0.04
Debt / FCF	0.25
Interest coverage	395.06
Long-term assets	$317.3M
Long-term liabilities	$29.2M
Net cash (debt)	$291.6M
Net cash / market cap	14.12%
Net cash growth	8.87%
Net debt / EBITDA	-4.09
Net debt / equity	-0.35
Net debt / FCF	-2.49
Piotroski F-Score	6
Property, plant and equipment	$126.9M
Shareholders' equity	$825.6M
Tangible book value	$825.6M
Tangible book value per share	$28.56
Total assets	$926M
Total cash	$320.7M
Total debt	$29.1M
Total liabilities	$100.4M
WACC	8.16%

Metric

Value

Altman Z-Score

15.39

Book value per share

$28.56

Debt / EBITDA

0.37

Debt / equity

0.04

Debt / FCF

0.25

Interest coverage

395.06

Long-term assets

$317.3M

Long-term liabilities

$29.2M

Net cash (debt)

$291.6M

Net cash / market cap

14.12%

Net cash growth

8.87%

Net debt / EBITDA

-4.09

Net debt / equity

-0.35

Net debt / FCF

-2.49

Piotroski F-Score

Property, plant and equipment

$126.9M

Shareholders' equity

$825.6M

Tangible book value

$825.6M

Tangible book value per share

$28.56

Total assets

$926M

Total cash

$320.7M

Total debt

$29.1M

Total liabilities

$100.4M

WACC

8.16%

Metric	Value
Asset turnover	1.04
Current assets	$608.7M
Current liabilities	$71.2M
Current ratio	8.55
Inventory turnover	0.85
Net working capital	$216.8M
Quick ratio	5.96
Working capital	$537.5M
Working capital turnover	1.77

Metric

Value

Asset turnover

1.04

Current assets

$608.7M

Current liabilities

$71.2M

Current ratio

8.55

Inventory turnover

0.85

Net working capital

$216.8M

Quick ratio

5.96

Working capital

$537.5M

Working capital turnover

1.77

Metric	Value
Buyback yield / dilution	3.84%
Dividend yield	0%
Shareholder yield	3.84%

Metric

Value

Buyback yield / dilution

3.84%

Dividend yield

Shareholder yield

3.84%

Metric	Value
150-day SMA	$55.78
1D price change	-0.31%
1M price change	1.62%
1M total return	1.62%
1W price change	0.43%
1W total return	0.43%
1Y price change	-8.38%
1Y return CAGR	-8.39%
1Y total return	-8.38%
20-day SMA	$70.02
200-day SMA	$58.81
3M price change	40.67%
3M total return	40.67%
3Y price change	-52.5%
3Y return CAGR	-21.97%
3Y total return	-52.5%
50-day SMA	$68.28
50-day SMA vs 200-day SMA	50over200
52-week high	$147.03
52-week high date	2025-12-10
52-week low	$38.91
52-week low date	2026-06-03
5Y price change	-72.35%
5Y return CAGR	-22.67%
5Y total return	-72.35%
6M price change	30.1%
6M total return	30.1%
All-time high	$330.00
All-time high date	2023-07-14
All-time low	$22.50
All-time low date	2018-05-03
Average true range (ATR)	$2.83
Average volume	764.8K
Beta (1Y)	1.64
Beta (2Y)	0.89
Beta (5Y)	0.73
Change from 52-week high	-51.66%
Change from 52-week low	82.68%
Change from all-time high	-78.29%
Change from all-time low	218.42%
Change from open	0.64%
Day's gap	-0.94%
Dollar volume	$17M
High price	$71.77
Low price	$70.63
Monthly RSI	41.84
Open price	$70.63
Position in 52-week range	39.47%
Premarket change	0.01%
Premarket close	$71.30
Premarket price	$71.31
Previous close	$71.30
Price vs 150-day SMA	28.44%
Price vs 20-day SMA	2.33%
Price vs 200-day SMA	21.83%
Price vs 50-day SMA	4.93%
Relative volume	0.31
RSI	55.4
Sharpe ratio	0.16
Sharpe ratio (3Y)	-0.08
Sharpe ratio (5Y)	-0.17
Sortino ratio	0.35
Sortino ratio (3Y)	-0.03
Sortino ratio (5Y)	-0.14
Volume	238.7K
Weekly RSI	57.71
YTD price change	-22.32%
YTD total return	-22.32%

Metric

Value

150-day SMA

$55.78

1D price change

-0.31%

1M price change

1.62%

1M total return

1.62%

1W price change

0.43%

1W total return

0.43%

1Y price change

-8.38%

1Y return CAGR

-8.39%

1Y total return

-8.38%

20-day SMA

$70.02

200-day SMA

$58.81

3M price change

40.67%

3M total return

40.67%

3Y price change

-52.5%

3Y return CAGR

-21.97%

3Y total return

-52.5%

50-day SMA

$68.28

50-day SMA vs 200-day SMA

50over200

52-week high

$147.03

52-week high date

2025-12-10

52-week low

$38.91

52-week low date

2026-06-03

5Y price change

-72.35%

5Y return CAGR

-22.67%

5Y total return

-72.35%

6M price change

30.1%

6M total return

30.1%

All-time high

$330.00

All-time high date

2023-07-14

All-time low

$22.50

All-time low date

2018-05-03

Average true range (ATR)

$2.83

Average volume

764.8K

Beta (1Y)

1.64

Beta (2Y)

0.89

Beta (5Y)

0.73

Change from 52-week high

-51.66%

Change from 52-week low

82.68%

Change from all-time high

-78.29%

Change from all-time low

218.42%

Change from open

0.64%

Day's gap

-0.94%

Dollar volume

$17M

High price

$71.77

Low price

$70.63

Monthly RSI

41.84

Open price

$70.63

Position in 52-week range

39.47%

Premarket change

0.01%

Premarket close

$71.30

Premarket price

$71.31

Previous close

$71.30

Price vs 150-day SMA

28.44%

Price vs 20-day SMA

2.33%

Price vs 200-day SMA

21.83%

Price vs 50-day SMA

4.93%

Relative volume

0.31

RSI

55.4

Sharpe ratio

0.16

Sharpe ratio (3Y)

-0.08

Sharpe ratio (5Y)

-0.17

Sortino ratio

0.35

Sortino ratio (3Y)

-0.03

Sortino ratio (5Y)

-0.14

Volume

238.7K

Weekly RSI

57.71

YTD price change

-22.32%

YTD total return

-22.32%

Metric	Value
Float	23.3M
Float percentage	80.49%
Shares change (QoQ)	0.84%
Shares change (YoY)	-3.84%
Shares held by insiders	1.29%
Shares held by institutions	111.09%
Shares outstanding	28.9M
Short % of float	18.03%
Short % of shares	14.51%
Short ratio	5 days

Metric

Value

Float

23.3M

Float percentage

80.49%

Shares change (QoQ)

0.84%

Shares change (YoY)

-3.84%

Shares held by insiders

1.29%

Shares held by institutions

111.09%

Shares outstanding

28.9M

Short % of float

18.03%

Short % of shares

14.51%

Short ratio

5 days

Inspire Medical Systems, Inc. (INSP)

Price

Financial snapshot

Fair-value bridge

Latest news · INSP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INSP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on INSP

Frequently asked questions